236 related articles for article (PubMed ID: 38068536)
1. Recent Advances and Future Challenges in Pancreatic Cancer Care: Early Detection, Liquid Biopsies, Precision Medicine and Artificial Intelligence.
Daamen LA; Molenaar IQ; Groot VP
J Clin Med; 2023 Dec; 12(23):. PubMed ID: 38068536
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic Ductal Adenocarcinoma (PDAC): A Review of Recent Advancements Enabled by Artificial Intelligence.
Mukund A; Afridi MA; Karolak A; Park MA; Permuth JB; Rasool G
Cancers (Basel); 2024 Jun; 16(12):. PubMed ID: 38927945
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in artificial intelligence for pancreatic ductal adenocarcinoma.
Hayashi H; Uemura N; Matsumura K; Zhao L; Sato H; Shiraishi Y; Yamashita YI; Baba H
World J Gastroenterol; 2021 Nov; 27(43):7480-7496. PubMed ID: 34887644
[TBL] [Abstract][Full Text] [Related]
4. Artificial Intelligence and Machine Learning in Pharmacological Research: Bridging the Gap Between Data and Drug Discovery.
Singh S; Kumar R; Payra S; Singh SK
Cureus; 2023 Aug; 15(8):e44359. PubMed ID: 37779744
[TBL] [Abstract][Full Text] [Related]
5. Hyperpolarized Magnetic Resonance and Artificial Intelligence: Frontiers of Imaging in Pancreatic Cancer.
Enriquez JS; Chu Y; Pudakalakatti S; Hsieh KL; Salmon D; Dutta P; Millward NZ; Lurie E; Millward S; McAllister F; Maitra A; Sen S; Killary A; Zhang J; Jiang X; Bhattacharya PK; Shams S
JMIR Med Inform; 2021 Jun; 9(6):e26601. PubMed ID: 34137725
[TBL] [Abstract][Full Text] [Related]
6. Application of liquid biopsy for surgical management of pancreatic cancer.
Nagai M; Sho M; Akahori T; Nakagawa K; Nakamura K
Ann Gastroenterol Surg; 2020 May; 4(3):216-223. PubMed ID: 32490335
[TBL] [Abstract][Full Text] [Related]
7. Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients.
Castillo J; Bernard V; San Lucas FA; Allenson K; Capello M; Kim DU; Gascoyne P; Mulu FC; Stephens BM; Huang J; Wang H; Momin AA; Jacamo RO; Katz M; Wolff R; Javle M; Varadhachary G; Wistuba II; Hanash S; Maitra A; Alvarez H
Ann Oncol; 2018 Jan; 29(1):223-229. PubMed ID: 29045505
[TBL] [Abstract][Full Text] [Related]
8. Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma.
Qian Y; Gong Y; Fan Z; Luo G; Huang Q; Deng S; Cheng H; Jin K; Ni Q; Yu X; Liu C
J Hematol Oncol; 2020 Oct; 13(1):130. PubMed ID: 33008426
[TBL] [Abstract][Full Text] [Related]
9. Leveraging Artificial Intelligence and Machine Learning in Regenerative Orthopedics: A Paradigm Shift in Patient Care.
Jeyaraman M; Ratna HVK; Jeyaraman N; Venkatesan A; Ramasubramanian S; Yadav S
Cureus; 2023 Nov; 15(11):e49756. PubMed ID: 38161806
[TBL] [Abstract][Full Text] [Related]
10. Navigating Glioblastoma Diagnosis and Care: Transformative Pathway of Artificial Intelligence in Integrative Oncology.
Ibrahim M; Muhammad Q; Zamarud A; Eiman H; Fazal F
Cureus; 2023 Aug; 15(8):e44214. PubMed ID: 37645667
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in precision medicine for pancreatic ductal adenocarcinoma.
Hayashi H; Higashi T; Miyata T; Yamashita YI; Baba H
Ann Gastroenterol Surg; 2021 Jul; 5(4):457-466. PubMed ID: 34337294
[TBL] [Abstract][Full Text] [Related]
12. Potential of artificial intelligence in the risk stratification for and early detection of pancreatic cancer.
Tovar DR; Rosenthal MH; Maitra A; Koay EJ
Artif Intell Surg; 2023; 3(1):14-26. PubMed ID: 37124705
[TBL] [Abstract][Full Text] [Related]
13. Artificial Intelligence Applications for Biomedical Cancer Research: A Review.
Weerarathna IN; Kamble AR; Luharia A
Cureus; 2023 Nov; 15(11):e48307. PubMed ID: 38058345
[TBL] [Abstract][Full Text] [Related]
14. From Machine Learning to Patient Outcomes: A Comprehensive Review of AI in Pancreatic Cancer.
Tripathi S; Tabari A; Mansur A; Dabbara H; Bridge CP; Daye D
Diagnostics (Basel); 2024 Jan; 14(2):. PubMed ID: 38248051
[TBL] [Abstract][Full Text] [Related]
15. Artificial intelligence for early detection of pancreatic adenocarcinoma: The future is promising.
Mendoza Ladd A; Diehl DL
World J Gastroenterol; 2021 Apr; 27(13):1283-1295. PubMed ID: 33833482
[TBL] [Abstract][Full Text] [Related]
16. Artificial intelligence and imaging for risk prediction of pancreatic cancer: a narrative review.
Qureshi TA; Javed S; Sarmadi T; Pandol SJ; Li D
Chin Clin Oncol; 2022 Feb; 11(1):1. PubMed ID: 35144387
[TBL] [Abstract][Full Text] [Related]
17. Exploring alternative approaches to precision medicine through genomics and artificial intelligence - a systematic review.
Mumtaz H; Saqib M; Jabeen S; Muneeb M; Mughal W; Sohail H; Safdar M; Mehmood Q; Khan MA; Ismail SM
Front Med (Lausanne); 2023; 10():1227168. PubMed ID: 37849490
[TBL] [Abstract][Full Text] [Related]
18. A review study on early detection of pancreatic ductal adenocarcinoma using artificial intelligence assisted diagnostic methods.
Sijithra PC; Santhi N; Ramasamy N
Eur J Radiol; 2023 Sep; 166():110972. PubMed ID: 37454557
[TBL] [Abstract][Full Text] [Related]
19. Nuclear translocation of the receptor tyrosine kinase c-MET reduces the treatment efficacies of olaparib and gemcitabine in pancreatic ductal adenocarcinoma cells.
Gao Y; Chen MK; Chu YY; Yang L; Yu D; Liu Y; Hung MC
Am J Cancer Res; 2021; 11(1):236-250. PubMed ID: 33520371
[TBL] [Abstract][Full Text] [Related]
20. Precision Medicine for
Principe DR
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
